206 related articles for article (PubMed ID: 2160320)
1. Calyculin A, an inhibitor of protein phosphatases, a potent tumor promoter on CD-1 mouse skin.
Suganuma M; Fujiki H; Furuya-Suguri H; Yoshizawa S; Yasumoto S; Kato Y; Fusetani N; Sugimura T
Cancer Res; 1990 Jun; 50(12):3521-5. PubMed ID: 2160320
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of action of okadaic acid class tumor promoters on mouse skin.
Fujiki H; Suganuma M; Yoshizawa S; Nishiwaki S; Winyar B; Sugimura T
Environ Health Perspect; 1991 Jun; 93():211-4. PubMed ID: 1663450
[TBL] [Abstract][Full Text] [Related]
3. Absence of synergistic effects on tumor promotion in CD-1 mouse skin by simultaneous applications of two different types of tumor promoters, okadaic acid and teleocidin.
Suganuma M; Yatsunami J; Yoshizawa S; Okabe S; Fujiki H
Cancer Res; 1993 Mar; 53(5):1012-6. PubMed ID: 8439947
[TBL] [Abstract][Full Text] [Related]
4. Diarrhetic shellfish toxin, dinophysistoxin-1, is a potent tumor promoter on mouse skin.
Fujiki H; Suganuma M; Suguri H; Yoshizawa S; Takagi K; Uda N; Wakamatsu K; Yamada K; Murata M; Yasumoto T
Jpn J Cancer Res; 1988 Oct; 79(10):1089-93. PubMed ID: 3143697
[TBL] [Abstract][Full Text] [Related]
5. A new pathway of tumor promotion by the okadaic acid class compounds.
Fujiki H; Suganuma M; Nishiwaki S; Yoshizawa S; Winyar B; Sugimura T; Schmitz FJ
Adv Second Messenger Phosphoprotein Res; 1990; 24():340-4. PubMed ID: 2169814
[No Abstract] [Full Text] [Related]
6. Okadaic acid: an additional non-phorbol-12-tetradecanoate-13-acetate-type tumor promoter.
Suganuma M; Fujiki H; Suguri H; Yoshizawa S; Hirota M; Nakayasu M; Ojika M; Wakamatsu K; Yamada K; Sugimura T
Proc Natl Acad Sci U S A; 1988 Mar; 85(6):1768-71. PubMed ID: 3126494
[TBL] [Abstract][Full Text] [Related]
7. Tautomycin: an inhibitor of protein phosphatases 1 and 2A but not a tumor promoter on mouse skin and in rat glandular stomach.
Suganuma M; Okabe S; Sueoka E; Nishiwaki R; Komori A; Uda N; Isono K; Fujiki H
J Cancer Res Clin Oncol; 1995; 121(9-10):621-7. PubMed ID: 7559747
[TBL] [Abstract][Full Text] [Related]
8. Protein phosphatase inhibitors and bone resorption: inhibition by okadaic acid and biphasic actions of calyculin-A.
Goad DL; Meurer EA; Voelkel EF; Petrou CP; Tashjian AH
Endocrinology; 1992 Jun; 130(6):3402-10. PubMed ID: 1375901
[TBL] [Abstract][Full Text] [Related]
9. Contrasting effects of calyculin A and okadaic acid on the respiratory burst of human neutrophils.
Djerdjouri B; Combadière C; Pedruzzi E; Hakim J; Périanin A
Eur J Pharmacol; 1995 Jan; 288(2):193-200. PubMed ID: 7720781
[TBL] [Abstract][Full Text] [Related]
10. Calyculin A and okadaic acid: inhibitors of protein phosphatase activity.
Ishihara H; Martin BL; Brautigan DL; Karaki H; Ozaki H; Kato Y; Fusetani N; Watabe S; Hashimoto K; Uemura D
Biochem Biophys Res Commun; 1989 Mar; 159(3):871-7. PubMed ID: 2539153
[TBL] [Abstract][Full Text] [Related]
11. Structure-activity relationship within a series of okadaic acid derivatives.
Nishiwaki S; Fujiki H; Suganuma M; Furuya-Suguri H; Matsushima R; Iida Y; Ojika M; Yamada K; Uemura D; Yasumoto T
Carcinogenesis; 1990 Oct; 11(10):1837-41. PubMed ID: 2170047
[TBL] [Abstract][Full Text] [Related]
12. Ability of okadaic acid and other protein phosphatase inhibitors to mimic the stimulatory effects of 12-O-tetradecanoylphorbol-13-acetate on hydroperoxide production in mouse epidermis in vivo.
Newell SW; Perchellet EM; Gao XM; Chen G; Perchellet JP
Cancer Lett; 1996 Jan; 98(2):241-51. PubMed ID: 8556715
[TBL] [Abstract][Full Text] [Related]
13. Inhibitors of protein phosphatase type 1 and 2A attenuate phosphatidylinositol metabolism and Ca(2+)-transients in human platelets. Role of a cdc2-related protein kinase.
Lerea KM
Biochemistry; 1992 Jul; 31(28):6553-61. PubMed ID: 1321663
[TBL] [Abstract][Full Text] [Related]
14. T cell apoptosis induced by interleukin-2 deprivation or transforming growth factor-beta 2: modulation by the phosphatase inhibitors okadaic acid and calyculin A.
Weller M; Malipiero U; Groscurth P; Fontana A
Exp Cell Res; 1995 Dec; 221(2):395-403. PubMed ID: 7493639
[TBL] [Abstract][Full Text] [Related]
15. Okadaic acid-induced actin assembly in neutrophils: role of protein phosphatases.
Downey GP; Takai A; Zamel R; Grinstein S; Chan CK
J Cell Physiol; 1993 Jun; 155(3):505-19. PubMed ID: 8388002
[TBL] [Abstract][Full Text] [Related]
16. Codon 61 mutations in the c-Harvey-ras gene in mouse skin tumors induced by 7,12-dimethylbenz[a]anthracene plus okadaic acid class tumor promoters.
Fujiki H; Suganuma M; Yoshizawa S; Kanazawa H; Sugimura T; Manam S; Kahn SM; Jiang W; Hoshina S; Weinstein IB
Mol Carcinog; 1989; 2(4):184-7. PubMed ID: 2508660
[TBL] [Abstract][Full Text] [Related]
17. Multidrug-resistant human KB carcinoma cells are highly resistant to the protein phosphatase inhibitors okadaic acid and calyculin A. Analysis of potential mechanisms involved in toxin resistance.
Chambers TC; Raynor RL; Kuo JF
Int J Cancer; 1993 Jan; 53(2):323-7. PubMed ID: 8093882
[TBL] [Abstract][Full Text] [Related]
18. Comparative effects of protein phosphatase inhibitors (okadaic acid and calyculin A) on human leukemia HL60, HL60/ADR and K562 cells.
Sakurada K; Zheng B; Kuo JF
Biochem Biophys Res Commun; 1992 Aug; 187(1):488-92. PubMed ID: 1325792
[TBL] [Abstract][Full Text] [Related]
19. An alternative theory of tissue specificity by tumor promotion of okadaic acid in glandular stomach of SD rats.
Suganuma M; Tatematsu M; Yatsunami J; Yoshizawa S; Okabe S; Uemura D; Fujiki H
Carcinogenesis; 1992 Oct; 13(10):1841-5. PubMed ID: 1330344
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of calyculin A and okadaic acid on the glucose-induced regulation of glycogen synthase and phosphorylase activities in cultured hepatocytes.
Pugazhenthi S; Yu B; Gali RR; Khandelwal RL
Biochim Biophys Acta; 1993 Nov; 1179(3):271-6. PubMed ID: 8218371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
